Meeting Banner
Abstract #3692

A multi-layer binary model with adaptive metabolite selection for multi-type brain tumour classification

Dadi Zhao1,2, Shivaram Avula3, Simon Bailey4, Sara Burling2, Tim Jaspan5,6, Lesley MacPherson7, Dipayan Mitra4, Paul S Morgan5,8,9, Barry Pizer10, Rui S Shen11, Martin Wilson12, Lara Worthington1,2,13, Theodoros N Arvanitis1,2,14, Andrew C Peet1,2, and John R Apps1,2
1Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom, 2Oncology, Birmingham Children's Hospital, Birmingham, United Kingdom, 3Alder Hey Children’s Hospital, Liverpool, United Kingdom, 4Paediatric Oncology, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom, 5Children's Brain Tumour Research Centre, University of Nottingham, Nottingham, United Kingdom, 6Neuroradiology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom, 7Radiology, Birmingham Children's Hospital, Birmingham, United Kingdom, 8Medical Physics, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom, 9Clinical Neuroscience, University of Nottingham, Nottingham, United Kingdom, 10Translational Research, University of Liverpool, Liverpool, United Kingdom, 11Bioengineering, University of Pennsylvania, Philadelphia, PA, United States, 12Centre for Human Brain Health, University of Birmingham, Birmingham, United Kingdom, 13RRPPS, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom, 14Engineering, University of Birmingham, Birmingham, United Kingdom

Synopsis

Keywords: Tumors (Pre-Treatment), Cancer

Motivation: Accurate classification of multi-type brain tumours through in vivo proton magnetic resonance spectroscopy remains a significant challenge. Conventional machine learning classifiers consider all reliably observed metabolites as features and classify all brain tumours simultaneously, but their performance is limited for rare tumour types.

Goal(s): This abstract presents a novel multi-layer classification model, binary adaptive metabolite selection (BAMS), for better identifying rare tumour types.

Approach: BAMS generalises the problem by considering only one specific brain tumour type and selecting significant biomarkers in each layer iteratively and dynamically.

Results: In comparison to classic models, BAMS showed significantly improved diagnostic performance for rare brain tumour types.

Impact: A brain tumour classification method that can only work on main types and cannot determine rare types is unlikely to be useful for clinicians. This abstract introduces BAMS that can significantly improve diagnostic performance for rare brain tumour types.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords